Survivin Antibody, anti-human, PE, REAfinity™, 100 tests in 200 µL
文献支持

Survivin Antibody, anti-human,

PE, REAfinity™, 100 tests in 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-118-962
  • 2025年12月09日
  • Intracellular flow cytometry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Survivin

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,2-8℃

    • 克隆性

      REA459

    • 标记物

      PE

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Intracellular flow cytometry

    • 浓度

      1:50

    • 抗体英文名

      Survivin Antibody, anti-human, REAfinity™

    • 抗体名

      Survivin Antibody, anti-human, REAfinity™

    • 规格

      100 tests in 200 µL

    Identification and enumeration of survivin+ cells by flow cytometryClone REA459 recognizes the human survivin antigen, a member of the inhibitor of apoptosis (IAP) family. Survivin is also known as baculoviral IAP repeat-containing protein 5 (BIRC5) or apoptosis inhibitor 4 (API4). The survivin protein inhibits caspase activation, thereby leading to negative regulation of apoptosis or programmed cell death. Expression of survivin is highly regulated by the cell cycle and is only expressed in the G2-M phase. Survivin localizes to the mitotic spindle by interaction with tubulin during mitosis and may play a contributing role in regulating mitosis. It is expressed highly in most human tumors and fetal tissue, but is completely absent in terminally differentiated cells. Its overexpression has been demonstrated in breast and lung cancer, prostate, gastric, colon, bladder and esophageal carcinomas, osteosarcomas, and lymphomas. Overexpression of survivin was also found to be significantly associated with a poor prognosis and decreased survival rates in oral, breast, and colorectal cancers. | Additional information: Clone REA459 displays negligible binding to Fc receptors.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Ambrosini, G. et al. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (8): 917–921. | Cheung, C. H. et al. (2013) Survivin - biology and potential as a therapeutic target in oncology. Onco Targets Ther. 16 (6): 1453–1462. | Fukuda, S. et al. (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 5 (5): 1087–1098.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年03月17日询价
    ¥5557
    苏州奕赛生物科技有限公司
    2025年07月10日询价
    ¥2299
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    询价
    武汉佰瑞得生物技术有限公司
    2025年11月27日询价
    文献支持
    Survivin Antibody, anti-human, PE, REAfinity™, 100 tests in 200 µL
    询价